​
Login / Signup
Sujinna Lekmeechai
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Uric Acid
Phase Ii Study
Squamous Cell
Weight Loss
Top Venues
Investigational new drugs
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Sujinna Lekmeechai
,
Kristian Pietras
,
Oskar Axelsson
177 Lu-SN201 nanoparticle shows superior anti-tumor efficacy over conventional cancer drugs in 4T1 orthotopic model.
Investigational new drugs
42 (4) (2024)
Sujinna Lekmeechai
,
Kristian Pietras
,
Oskar Axelsson
177 Lu-SN201 nanoparticle shows superior anti-tumor efficacy over conventional cancer drugs in 4T1 orthotopic model.
Investigational new drugs
42 (4) (2024)
Sujinna Lekmeechai
,
Kristian Pietras
,
Oskar Axelsson
177 Lu-SN201 nanoparticle shows superior anti-tumor efficacy over conventional cancer drugs in 4T1 orthotopic model.
Investigational new drugs
42 (4) (2024)
Sujinna Lekmeechai
,
Kristian Pietras
,
Oskar Axelsson
177 Lu-SN201 nanoparticle shows superior anti-tumor efficacy over conventional cancer drugs in 4T1 orthotopic model.
Investigational new drugs
(2024)